companydata.dkcompanydata.dk

NW BIOTECH INVEST ApS: Financial statements 2012

CVR: 25942167

Source: annual report 2012, Danish Business Authority

01/01/2012 – 31/12/2012

NW BIOTECH INVEST ApS (CVR 25942167) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -23,640 and a net result of DKK 4,119,919. Equity in the 2012 report amounted to DKK 1,223,158. The solvency ratio was 19.4%.

Gross Profit
DKK -23,640
Profit/Loss
DKK 4,119,919
Equity
DKK 1,223,158
Total Assets
DKK 6,303,967

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NW BIOTECH INVEST ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2012

NW BIOTECH INVEST ApS appoints new auditorMar 13, 2012

As of March 13, 2012, RVT REVISIONSTJENESTEN A/S has been appointed auditor of NW BIOTECH INVEST ApS.

Auditor steps down at NW BIOTECH INVEST ApSMar 13, 2012

As of March 13, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NW BIOTECH INVEST ApS.

About NW BIOTECH INVEST ApS

NW BIOTECH INVEST ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2001. The company has been dissolved on 10 August 2018. The company was registered under the industry Uoplyst. The company was previously named GFKJUS 637 ApS. In 2013, the company reported a gross profit of DKK -18,983 and a net result of DKK -6,270,866 compared with DKK 4,119,919 the year before. Equity in the 2013 report amounted to DKK -5,047,708.

Source: annual report 2013, Danish Business Authority

Other financial years